An increased incidence of endometrial cancer has been found in association with prolonged, unopposed estrogen (E2) exposure [2, 3] and alterations in the expression of the tumor suppressor gene, PTEN, as well as the oncogenes, β-catenin and Ras [4, 5]. This evidence concerns the gene PTEN and endometrial cancer.